全文获取类型
收费全文 | 322篇 |
免费 | 24篇 |
专业分类
儿科学 | 3篇 |
基础医学 | 42篇 |
临床医学 | 14篇 |
内科学 | 3篇 |
神经病学 | 264篇 |
特种医学 | 6篇 |
外科学 | 5篇 |
综合类 | 2篇 |
预防医学 | 4篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 2篇 |
2020年 | 5篇 |
2019年 | 4篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 6篇 |
2015年 | 2篇 |
2014年 | 5篇 |
2013年 | 16篇 |
2012年 | 7篇 |
2011年 | 17篇 |
2010年 | 6篇 |
2009年 | 10篇 |
2008年 | 18篇 |
2007年 | 10篇 |
2006年 | 14篇 |
2005年 | 14篇 |
2004年 | 19篇 |
2003年 | 13篇 |
2002年 | 17篇 |
2001年 | 12篇 |
2000年 | 22篇 |
1999年 | 9篇 |
1998年 | 9篇 |
1997年 | 5篇 |
1996年 | 5篇 |
1995年 | 4篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 11篇 |
1991年 | 13篇 |
1990年 | 8篇 |
1989年 | 8篇 |
1988年 | 11篇 |
1987年 | 7篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 2篇 |
排序方式: 共有346条查询结果,搜索用时 15 毫秒
71.
72.
73.
Pooja Singhmar XiaoJiao Huo Niels Eijkelkamp Susana Rojo Berciano Faiza Baameur Fang C. Mei Yingmin Zhu Xiaodong Cheng David Hawke Federico Mayor Jr. Cristina Murga Cobi J. Heijnen Annemieke Kavelaars 《Proceedings of the National Academy of Sciences of the United States of America》2016,113(11):3036-3041
74.
75.
I. Mateo J. Infante P. Sánchez‐Juan I. García‐Gorostiaga E. Rodríguez‐Rodríguez J. L. Vázquez‐Higuera J. Berciano O. Combarros 《Acta neurologica Scandinavica》2010,121(2):136-138
Mateo I, Infante J, Sánchez‐Juan P, García‐Gorostiaga I, Rodríguez‐Rodríguez E, Vázquez‐Higuera JL, Berciano J, Combarros O. Serum heme oxygenase‐1 levels are increased in Parkinson’s disease but not in Alzheimer’s disease.Acta Neurol Scand: 2010: 121: 136–138.© 2009 The Authors Journal compilation © 2009 Blackwell Munksgaard. Objective – Oxidative stress is implicated in Parkinson’s disease (PD) and Alzheimer’s disease (AD), and heme oxygenase‐1 (HO‐1) is a potent antioxidant overexpressed in PD substantia nigra and AD cerebral cortex and hippocampus, indicating a possible up‐regulation of antioxidant defenses in both neurodegenerative diseases. The role of HO‐1 in peripheral blood of PD and AD patients remains unresolved. Methods – We measured serum HO‐1 levels in 107 patients with PD, 105 patients with AD, 104 controls for PD and 120 controls for AD. Results – The median serum concentration of HO‐1 was significantly higher in PD patients (2.04 ng/ml) compared with that of PD controls (1.69 ng/ml, P = 0.016), with PD patients predominating over controls in the upper tertile of serum HO‐1 levels, whereas there was more PD controls than PD patients in the lower tertile (P = 0.006). Median serum levels of HO‐1 did not differ significantly between AD patients and AD controls. Conclusion – The increase of serum HO‐1 levels in PD patients could indicate a systemic antioxidant reaction related to a chronic oxidative stress state in PD brain. 相似文献
76.
Infante J Sánchez-Juan P Mateo I Rodríguez-Rodríguez E Sánchez-Quintana C Llorca J Fontalba A Terrazas J Oterino A Berciano J Combarros O 《Journal of the neurological sciences》2007,256(1-2):68-70
Poly (ADP-ribose) polymerase-1 (PARP-1) is involved in crucial pathogenic events in Parkinson's disease (PD). We studied the effect of promoter variations of PARP-1 gene on the risk for PD in a case-control association study comprising 146 PD patients and 161 controls from Northern Spain. Three polymorphisms from the promoter region of PARP-1 gene were analyzed: -410C/T, -1672G/A, and a (CA)n microsatellite. A protective effect against PD was found for heterozygosity at (-410) (OR 0.44) and (CA)n microsatellite (OR 0.53) polymorphisms, and heterozygosity at (-1672) polymorphism delayed by 4 years on the onset age of PD. Variations in the regulatory region of PARP-1 gene might modify the risk for PD. 相似文献
77.
78.
Rodríguez-Rodríguez E Infante J Llorca J Mateo I Sánchez-Quintana C García-Gorostiaga I Sánchez-Juan P Berciano J Combarros O 《Neurobiology of aging》2009,30(2):322-324
An association between memory performance in healthy young, middle aged an elderly subjects and variability in the KIBRA gene (rs17070145) has been recently described. We analyzed this polymorphism in 391 sporadic Alzheimer's disease (AD) patients and 428 cognitively normal control subjects. The current study reveals that KIBRA (rs17070145) T allele (CT and TT genotypes) is associated with an increased risk (OR 2.89; p=0.03) for very-late-onset (after the age of 86 years) AD. 相似文献
79.
Infante J Rodríguez E Combarros O Mateo I Fontalba A Pascual J Oterino A Polo JM Leno C Berciano J 《Neuroscience letters》2006,395(3):224-226
Mutations in the leucine-rich repat kinase 2 (LRRK2) gene have been shown to cause both autosomal dominant and sporadic Parkinson's disease (PD). The common G2019S mutation shows wide geographical distribution while R1441G has been only reported in Northern Spain. The overall frequency of these mutations remains to be established. To determine the prevalence of G2019S and R1441G mutations in our population of Cantabria (Northern Spain), we recruited 105 consecutive PD patients and 310 controls and conducted genetic analysis of these mutations. G2019S was detected in eight late-onset patients (7.6%). Five of them had no relevant family history. R1441G was not detected in any of our study subjects. The prevalence of G2019S mutation in unselected late-onset PD patients might be higher than previously reported: 3/16 (18.7%) of familial PD and 5/82 (6.1%) of sporadic PD. 相似文献
80.
Eloy Rodríguez Ignacio Mateo Javier Llorca Coro Sánchez-Quintana Jon Infante José Berciano Onofre Combarros 《American journal of medical genetics. Part B, Neuropsychiatric genetics》2006,(5):541-543
A number of studies suggest that brain cholesterol metabolism may play a role in Alzheimer's disease (AD) development, probably through modulation of amyloid beta production. The discovery that apolipoprotein E (APOE) epsilon4 allele is a risk factor for sporadic AD raises the possibility that the receptors to which APOE binds on the surface of neurons are also involved in the neurodegenerative process. To evaluate the relationship between low density lipoprotein receptor (LDLR) genetic variant and AD, independently or in concert with the APOE epsilon4 allele, we examined three LDLR polymorphisms located in exons 8 (rs 11669576), 10 (rs 5930), and 13 (rs 5925), in a large group of 322 Spanish AD patients and 314 controls. The current study does not demonstrate an association between LDLR genotypes or haplotypes and AD, neither in the total sample nor when the populations were stratified for the presence or absence of the APOE epsilon4 allele. 相似文献